1. Home
  2. MTEX vs ABP Comparison

MTEX vs ABP Comparison

Compare MTEX & ABP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTEX
  • ABP
  • Stock Information
  • Founded
  • MTEX 1993
  • ABP 2004
  • Country
  • MTEX United States
  • ABP United States
  • Employees
  • MTEX N/A
  • ABP N/A
  • Industry
  • MTEX Medicinal Chemicals and Botanical Products
  • ABP Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTEX Health Care
  • ABP Health Care
  • Exchange
  • MTEX Nasdaq
  • ABP Nasdaq
  • Market Cap
  • MTEX 15.8M
  • ABP 15.2M
  • IPO Year
  • MTEX 1999
  • ABP N/A
  • Fundamental
  • Price
  • MTEX $8.68
  • ABP $0.21
  • Analyst Decision
  • MTEX
  • ABP Hold
  • Analyst Count
  • MTEX 0
  • ABP 1
  • Target Price
  • MTEX N/A
  • ABP N/A
  • AVG Volume (30 Days)
  • MTEX 48.5K
  • ABP 4.8M
  • Earning Date
  • MTEX 11-07-2025
  • ABP 11-18-2025
  • Dividend Yield
  • MTEX N/A
  • ABP N/A
  • EPS Growth
  • MTEX N/A
  • ABP N/A
  • EPS
  • MTEX N/A
  • ABP N/A
  • Revenue
  • MTEX $112,975,000.00
  • ABP $183,000.00
  • Revenue This Year
  • MTEX N/A
  • ABP N/A
  • Revenue Next Year
  • MTEX N/A
  • ABP N/A
  • P/E Ratio
  • MTEX N/A
  • ABP N/A
  • Revenue Growth
  • MTEX N/A
  • ABP 154.17
  • 52 Week Low
  • MTEX $7.22
  • ABP $0.15
  • 52 Week High
  • MTEX $16.49
  • ABP $11.19
  • Technical
  • Relative Strength Index (RSI)
  • MTEX 46.89
  • ABP 49.33
  • Support Level
  • MTEX $8.76
  • ABP $0.19
  • Resistance Level
  • MTEX $9.16
  • ABP $0.21
  • Average True Range (ATR)
  • MTEX 0.62
  • ABP 0.02
  • MACD
  • MTEX -0.05
  • ABP 0.00
  • Stochastic Oscillator
  • MTEX 6.21
  • ABP 59.64

About MTEX Mannatech Incorporated

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

About ABP Abpro Holdings Inc Common Stock

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

Share on Social Networks: